A Spanish observational cohort study indicated that ambulatory blood pressure (BP), particularly night-time BP, was more informative about the risk of all-cause and cardiovascular death than clinic BP. The study used clinic and ambulatory BP data obtained from 59124 patients between March 1, 2004, to Dec 31, 2014. During a median follow-up of 9·7 years, 7174 (12·1%) patients died, including 2361 (4·0%) from cardiovascular causes. Cox models were used to estimate associations between usual clinic or ambulatory BP and mortality. J-shaped associations were observed for several BP measures. Among the top four baseline-defined quintiles, 24-h systolic BP was more strongly associated with all-cause death (hazard ratio [HR] 1·41 per 1 – SD increment) than clinic systolic BP (HR 1·18). The association between 24-h BP with all-cause deaths remained strongly when adjusted for clinic BP (HR 1·43), but the association between clinic BP and all-cause death was attenuated when adjusted for 24-h BP (HR 1·04). Compared with clinic systolic BP (100%), night-time systolic BP was most informative about risk of all-cause death (591%) and cardiovascular death (604%). Relative to BP within the normal range, elevated all-cause and cardiovascular mortality risks were observed for masked hypertension (HR 1·24 and 1.37, respectively) and sustained hypertension (HR 1·24 and 1.38, respectively), but not white-coat hypertension. The study extends findings of previous population and clinical studies and demonstrates the mortality of common BP phenotypes. Source: https://www.thelancet.com/
A study revealed that stroke remains a major global health challenge, influenced by numerous risk…
A systematic review and meta-analysis evaluated randomized controlled trials on pharmacological treatments for anxiety in…
A global study suggested that most patients with coronary heart disease (CHD) have Lipoprotein (a)…
A recent article explored the science and skepticism surrounding seed oils. These oils—extracted from sources…
A Canadian study of adults with high blood pressure (BP) found no difference in health…
Two randomized, controlled trials evaluated the efficacy and safety of obicetrapib, an oral cholesteryl ester…
This website uses cookies.